行情

QTNT

QTNT

Quotient
NASDAQ

实时行情|Nasdaq Last Sale

3.880
+0.240
+6.59%
已收盘, 16:00 04/02 EDT
开盘
3.590
昨收
3.640
最高
3.940
最低
3.550
成交量
23.95万
成交额
--
52周最高
11.30
52周最低
2.395
市值
3.12亿
市盈率(TTM)
-2.5100
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测QTNT价格均价为13.50,最高价位14.00,最低价为13.00。

EPS

QTNT 新闻

更多
  • 俄罗斯据称为今年20美元的油价做准备 将发行更多债券
  • 新浪美股 · 20分钟前
  • 黄金期货周四收高2.9% 5日来首次收高
  • 新浪美股 · 24分钟前
  • 60%的美国人认为经济"糟糕" 而1月份时67%认为经济"良好"
  • 新浪美股 · 35分钟前
  • 瑞幸爆出财务造假丑闻 股价一度狂跌八成
  • 新浪美股 · 1小时前

所属板块

医疗设备、用品及经销
+2.96%
医疗设备和用品
+3.41%

热门股票

代码
价格
涨跌幅

QTNT 简况

Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. It is engaged in developing MosaiQ, which is its technology platform. The Company develops, manufactures and commercializes the products, including antisera products, reagent red blood cells, whole blood controls and ancillary products. Its antisera products contain antibodies used to identify blood group antigens. Its antisera products are monoclonal antibodies manufactured from master cell lines it owns. Its reagent red blood cells products are composed of human red blood cells formulated to enable the identification of blood group antibodies. The Company develops, manufactures and sells conventional reagent products to original equipment manufacturers (OEMs).
展开

微牛提供Quotient Ltd(NASDAQ-QTNT)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的QTNT股票新闻,以帮助您做出投资决策。